Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jun;51(5):107500.
doi: 10.1016/j.burns.2025.107500. Epub 2025 Apr 17.

Early Laser for Burn Scars (ELABS) - Randomised controlled trial of pulsed dye laser treatment and standard care versus standard care alone for the treatment of hypertrophic burn scars

Mark P Brewin  1 , Sharon Docherty  2 , Vanessa Heaslip  3 , Shelley Rhodes  4 , Obioha C Ukoumunne  4 , Naomi C Burnett-Fry  4 , Katie Breheny  5 , Jonathon M Pleat  6 , Kate M Attrill  7 , Kayvan Shokrollahi  8 , Quentin Frew  9 , Christopher J Lewis  10
Affiliations
Free article
Randomized Controlled Trial

Early Laser for Burn Scars (ELABS) - Randomised controlled trial of pulsed dye laser treatment and standard care versus standard care alone for the treatment of hypertrophic burn scars

Mark P Brewin et al. Burns. 2025 Jun.
Free article

Abstract

Background: Hypertrophic burn scarring (HBS) is described as "the greatest unmet challenge after burn injury". This ELABS trial hypothesised that early pulsed dye laser (PDL) treatment of HBS improves both scar quality and quality of life (QoL).

Methods: A parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of PDL was undertaken at seven centres in the UK. Patients were eligible if their burn injury was within three months of wound healing, and ineligible either with history of keloid scarring or aged < 16 years. A total of 153 (77 male, 76 female) participants were recruited between Nov 17, 2021, and Jun 30, 2023, and were randomised using software in a 1:1 ratio stratified by study centre; 138 (69 each arm) were included in the final complete-case analysis. Both study arms received standard care, and the intervention arm received three PDL treatments. The primary outcome was patient-rated scar quality (POSAS) at six months. The trial was registered with International Standard Randomised Controlled Trial Number registry (ISRCTN14392301).

Findings: Early PDL showed a statistically significant improvement in patient-rated scar quality (p = 0·041) and the secondary outcome, participant's perception of change in scar quality (p = 0·01), at six months. There were no statistically significant differences for Quality-of-Life, observer-rated POSAS scar quality, or colour measurement. Early PDL was not cost-effective at 6 months follow-up for the willingness-to-pay threshold of £20,000 per Quality-Adjusted-Life-Year (QALY). There were no unexpected adverse events related to the intervention.

Interpretation: Early PDL treatment of HBS is safe and shows improvement for patient-rated scar quality but not QoL at six months. As scar maturation is prolonged and dynamic, longer-term follow-up of upwards of two years is required both to understand the eventual clinical effect on scar outcome and to make any definitive conclusion concerning cost-effectiveness.

Keywords: Burn injury; Hypertrophic Scar; POSAS; Pulsed Dye Laser; Quality-of-Life; RCT.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest We declare no competing interests. OU was supported by the NIHR Applied Research Collaboration South West Peninsula. The project was funded by the National Institute for Health and Care Research (NIHR201080, United Kingdom) on the Research for Patient Benefit Programme.

Publication types